Maximizing wound coverage in full-thickness skin defects: A randomized-controlled trial of autologous skin cell suspension and widely meshed autograft versus standard autografting
Authors:
- Sharon HenrySHSharon Henry
- Steven MapulaSMSteven Mapula
- Mark GreviousMGMark Grevious
- Kevin N. FosterKFKevin N. Foster
- Herbert PhelanHPHerbert Phelan
- Jeffrey ShuppJSJeffrey Shupp
- Rodney ChanRCRodney Chan
- David HarringtonDHDavid Harrington
- Neil MashruwalaNMNeil Mashruwala
- David A. BrownDBDavid A. Brown
- Haaris MirHMHaaris Mir
- George SingerGSGeorge Singer
Open Access
- 1 September 2023
- journal article
- conference paper
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 96 (1) , 85-93
Abstract
BACKGROUND: Traumatic insults, infection, and surgical procedures can leave skin defects that are not amenable to primary closure. Split-thickness skin grafting (STSG) is frequently used to achieve closure of these wounds. Although effective, STSG can be associated with donor site morbidity, compounding the burden of illness in patients undergoing soft tissue reconstruction procedures. With an expansion ratio of 1:80, autologous skin cell suspension (ASCS) has been demonstrated to significantly decrease donor skin requirements compared with traditional STSG in burn injuries. We hypothesized that the clinical performance of ASCS would be similar for soft tissue reconstruction of nonburn wounds. METHODS: A multicenter, within-patient, evaluator-blinded, randomized-controlled trial was conducted of 65 patients with acute, nonthermal, full-thickness skin defects requiring autografting. For each patient, two treatment areas were randomly assigned to concurrently receive a predefined standard-of-care meshed STSG (control) or ASCS + more widely meshed STSG (ASCS+STSG). Coprimary endpoints were noninferiority of ASCS+STSG for complete treatment area closure by Week 8, and superiority for relative reduction in donor skin area. RESULTS: At 8 weeks, complete closure was observed for 58% of control areas compared with 65% of ASCS+STSG areas (p = 0.005), establishing noninferiority of ASCS+STSG. On average, 27.4% less donor skin was required with ASCS+ STSG, establishing superiority over control (p < 0.001). Clinical healing (≥95% reepithelialization) was achieved in 87% and 85% of Control and ASCS+STSG areas, respectively, at 8 weeks. The treatment approaches had similar long-term scarring outcomes and safety profiles, with no unanticipated events and no serious ASCS device-related events. CONCLUSION: ASCS+STSG represents a clinically effective and safe solution to reduce the amount of skin required to achieve definitive closure of full-thickness defects without compromising healing, scarring, or safety outcomes. This can lead to reduced donor site morbidity and potentially decreased cost associated with patient care. Clincaltrials.gov identifier: NCT04091672 LEVEL OF EVIDENCE: Therapeutic/Care Management; Level I.Keywords
This publication has 22 references indexed in Scilit:
- Restoring full-thickness defects with spray skin in conjunction with dermal regenerate template and split-thickness skin grafting: a pilot studyJournal of Tissue Engineering and Regenerative Medicine, 2017
- Back Grafting the Split-Thickness Skin Graft Donor SiteJournal of Burn Care & Research, 2017
- A Case Report of the First Nonburn-related Military Trauma Victim Treated with Spray Skin Regenerative Therapy in Combination with a Dermal Regenerate TemplatePlastic and Reconstructive Surgery - Global Open, 2016
- Characterisation of the cell suspension harvested from the dermal epidermal junction using a ReCell® kitBurns, 2012
- The Hypermetabolic Response to Burn Injury and Interventions to Modify this ResponseClinics in Plastic Surgery, 2009
- The hidden cost of skin scars: quality of life after skin scarringJournal of Plastic, Reconstructive & Aesthetic Surgery, 2008
- A randomized trial comparing ReCell® system of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burnsBurns, 2007
- Perioperative Care of the Immunocompromised PatientAORN Journal, 2007
- The Patient and Observer Scar Assessment Scale: A Reliable and Feasible Tool for Scar EvaluationPlastic and Reconstructive Surgery, 2004
- Sprayed Keratinocyte Suspensions Accelerate Epidermal Coverage in a Porcine Microwound ModelJournal of Burn Care & Rehabilitation, 2000